TURKEY. Prof.Dr.F.Nur BARAN AKSAKAL Prof.Dr. Serhat ÜNAL. 6th Mena Influenza Stakeholders Meeting. Organized by Fondation Mérieux

Similar documents
PAKISTAN (COUNTRY ACTION PLAN PRESENTATION)

KSA Dr. Muslim Abu Hassan EPI Manager & Head of Influenza Vaccination Program

Egypt (Action plan )

Seasonal Influenza Report

History, Achievements and Future Direction

Seasonal Influenza Report

Gaps in Influenza Clinical Research. Presented by: Dr Gina Samaan Technical Officer, Indonesia Field Epidemiology Training Program

Disparities in influenza vaccination coverage rates in health care workers and the ways to overcome the barriers

Influenza vaccination situation in Middle-East and North Africa countries Report of the 7 th MENA Influenza Stakeholders Network (MENA-ISN)

MOROCCO. 9th MENA Influenza Stakeholders Networks Meeting. Copenhagen, Denmark 04-5 October, Jalal NOURLIL

Seasonal Influenza Report

Seasonal Influenza Report

Austin Public Health Epidemiology and Disease Surveillance Unit. Travis County Influenza Surveillance

Seasonal Influenza Report

H1N1 Vaccine Based on CDCs ACIP Meeting, July 29, 2009

Influenza, Board of Health Monthly Meeting February 14, 2018 Jenifer Leaf Jaeger, MD, MPH Interim Medical Director

Flu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Key facts about influenza vaccine

The World Medical Association Campaign for Physician Immunization to Prevent Influenza Outbreaks

MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 4, 2019

A multidisciplinary scientifically independent network of. European Scientists Fighting Influenza 2014

MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH WEEKLY INFLUENZA UPDATE January 26, 2018

SCHOOL- BASED TYPHOID VACCINATION PROGRAM IN KARACHI: POLICY IMPLICATIONS FOR TYPHOID CONTROL

Surveillance of Influenza in Northern Ireland

RESULTS OF SEASON Serhat Unal M.D. Ankara, TURKEY

MDPH Influenza Update

Flu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance

Priority Area: 1 Access to Oral Health Care

20. The purpose of this document is to examine the pre-pandemic efforts and the response to the new influenza A (H1N1) virus since April 2009.

Weekly Influenza & Respiratory Activity: Statistics Summary

Weekly Influenza Activity: Statistics Summary

What do epidemiologists expect with containment, mitigation, business-as-usual strategies for swine-origin human influenza A?

Nova Scotia s Response to H1N1. Summary Report

ILI Syndromic Surveillance

HPS Monthly National Seasonal Respiratory Report

Indiana Immunization Task Force Progress Report

RESPIRATORY VIRUS SURVEILLANCE REPORT

Influenza A(H1N1)2009 pandemic Chronology of the events in Belgium

Weekly Influenza Surveillance Report. Week 11

Influenza Surveillance Animal and Public Health Partnership. Jennifer Koeman Director, Producer and Public Health National Pork Board

Chinese Influenza Weekly Report

Summary Report EU Health Award 2017

-VFC Providers Influenza Vaccine and Preparedness Survey: Oregon-

LOGFRAME TEMPLATE FOR SWAZILAND. SIDA s Contributions

Influenza: A recap of the season

ELIMINATION OF VIRAL HEPATITIS IN ROMANIA LESSONS LEARNT AND THE WAY FORWARD

Utah Influenza Report This report contains data through the week ending 12/15/2012 (MMWR week 50).

2007 ACIP Recommendations for Influenza Vaccine. Anthony Fiore, MD, MPH Influenza Division, NCIRD, CDC

VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...

VIRAL HEPATITIS: SITUATION ANALYSIS AND PERSPECTIVES IN THE AFRICAN REGION. Report of the Secretariat. CONTENTS Paragraphs BACKGROUND...

REPORT OF THE COUNCIL ON SCIENCE AND PUBLIC HEALTH. AMA Policy Consolidation: Influenza and Influenza Vaccine

Surveillance of influenza in Northern Ireland

HPS Weekly National Seasonal Respiratory Report

Past Influenza Pandemics


Influenza Weekly Surveillance Bulletin

-VFC Providers Influenza Vaccine and Preparedness Survey: Louisiana-

Update on Healthcare Personnel Influenza Vaccination

Improving Type 2 Diabetes Therapy Compliance and Persistence in Brazil

Oregon s Weekly Surveillance Report for Influenza and other Respiratory Viruses

MEMORANDUM. RE: Ontario Influenza and Respiratory Infection Surveillance Program

Influenza Situation Update

Summary of the National Adult and Influenza Vaccine Summit (NAIIS) May 14-16, L.J Tan Chief Strategy Officer, IAC Co-Chair, NAIIS

Centers for Disease Control and Prevention U.S. INFLUENZA SEASON SUMMARY*

Running head: INFLUENZA VIRUS SEASON PREPAREDNESS AND RESPONSE 1

Influenza Surveillance to Inform Decision Making

Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU

Influenza Weekly Surveillance Bulletin

The Influenza Season Stephen L. Cochi, M.D., M.P.H. Acting Director National Immunization Program, CDC

Influenza Virus: Evolution of a Deadly Virus in our World

Manitoba Influenza Surveillance Report

Promoting Public Health Security Addressing Avian Influenza A Viruses and Other Emerging Diseases

INFLUENZA WEEKLY UPDATE 2014/27: 30 June 6 July 2014

Influenza-Associated Hospitalization and Death Surveillance: Dallas County

Update on A(H1N1) pandemic and seasonal vaccine availability. July 7, 2009

Adult Immunizations Carolyn B. Bridges, MD

NC IMMUNIZATION COALITION FLU THEN AND NOW NC DHHS COMMUNICABLE DISEASE BRANCH ANITA VALIANI, MPH AUGUST 1, 2018

It Takes A Village to Curb the Prescription Opioid Epidemic: Supply healthcare providers with resources to improve patient safety

Regional Update EW 46 Influenza (November 28, h GMT; 12 h EST)

Infectious Diseases, Chronic Diseases District of Columbia Department of Health, Center for Policy, Planning & Evaluation Assignment Description

INFLUENZA WEEKLY UPDATE 2014/25: June 2014


We ll be our own lifesavers. We ll get the flu vaccine.

Influenza. Influenza vaccines (WHO position paper) Weekly Epid. Record (2005, 80: ) 287

Ensuring the quality of polio outbreak response activities: A rationale and guide for 3 month, quarterly and 6 month independent assessments

Dr Mary O Meara Specialist in Public Health Medicine November /9/2013 1

Influenza Weekly Surveillance Bulletin

County of Los Angeles Department of Health Services Public Health

Alberta Health. Seasonal Influenza in Alberta Season Summary

Western Pacific Regional Office of the World Health Organization.

Weekly Influenza & Respiratory Illness Activity Report

10/29/2014. Influenza Surveillance and Reporting. Outline

Minnesota Influenza Geographic Spread

ARIZONA INFLUENZA SUMMARY

Vaccine hesitancy in the EU: state of play and impact on vaccination programmes

Minnesota Influenza Geographic Spread

Conclusions of the high level hearing on seasonal influenza 30 April 2015, Luxembourg Michael Sulzner

Strategies to increase the uptake of the influenza vaccine by healthcare workers: A summary of the evidence

Surveillance Overview

Transcription:

TURKEY Prof.Dr.F.Nur BARAN AKSAKAL Prof.Dr. Serhat ÜNAL 6th Mena Influenza Stakeholders Meeting Organized by Fondation Mérieux Prague, Czech Republic 6-7 April 2017

MENA ISN OBJECTIVES (for reference purposes) 1. Improve Surveillance and Disease Burden Data Support the WHO initiative in building laboratory capacity and surveillance in the MENA region and urge the governments to give high priority to the establishment and continued support for influenza surveillance systems. Identify the needs of countries for establishing or improving existing surveillance networks Disseminate surveillance and disease burden data through publications. 2. Increase the Evidence-based Communication on Influenza Burden and Benefits of Vaccination Bring together key stakeholders to in local country identify and discuss common concerns and challenges in communicating the importance and benefits of seasonal influenza vaccination, addressing misinformation Be the active advocate for acceptance of vaccinationby health professionals and the public Identify effective communication tools 3. Increase the Number of Countries with Flu Vaccination in Their National Immunization Programs Provide/increase official recommendations for influenza vaccination Provide /increase funding for vaccination by governments 1. Improve the Monitoring of Influenza Coverage Rates to Increase the Rates Define barriers and drivers among lay public, Health Care Staff and Health Authorities Set official «vaccination coverage rate targets» customized to the countries Develop actions to increase vaccination coverage rates in pregnant women, people at risk, elderly and children (vaccination campaigns)

COUNTRY OBJECTIVES FOR THE UPCOMING 3 YEARS Increase the Evidence-based Communication on Influenza Burden and Benefits of Vaccination Bring together key stakeholders to in local country identify and discuss common concerns and challenges in communicating the importance and benefits of seasonal influenza vaccination, addressing misinformation Be the active advocate for acceptance of vaccination by health professionals and the public Identify effective communication tools

COUNTRY OBJECTIVES FOR THE UPCOMING 3 YEARS Improve Surveillance and Disease Burden Data Disseminate surveillance and disease burden data through publications. Communicate the burden with HPs and the public Improve the Monitoring of Influenza Coverage Rates to Increase the Rates Develop actions to increase vaccination coverage rates in pregnant women, people at risk, elderly and children (vaccination campaigns)

COUNTRY OBJECTIVES FOR THE UPCOMING 3 YEARS Implementation of increasing VCR strategy in elderly Preparation and implementation of a national adult vaccination programme with a life-long immunization approach including: Adult vaccination calender (There is one recommended by a group of associations with the participation of MoH representatives) Setting targets for elderly and risk groups Recording and follow-up of vaccinations A better surveillance programme including hospital-based surveillance

COUNTRY EPIDEMIOLOGICAL UPDATE TURKEY 1. 2016-2017 /43.wk- Ongoing 2015-2016 influenza season: Start: 44th week 2015 ( October 26- November 01, 2015) End : 19th week 2016 (May 09-15, 2016) 1. Circulating viruses: Influenza A H3N2, Influenza B 2. Subtypes / lineages : NA (Not tested yet) 3. Severity of the epidemics: 758 /2833 samples (26.8%) NA

TURKEY EPIDEMIOLOGICAL UPDATE Circulating viruses http://www.thsk.gov.tr/dosya/birimler/bulasici_hastaliklar_db/dokumanlar/grip/2017/haftalik_influenzagrip_surveyans_raporu_2017_ 12_hafta.pdf

TURKEY EPIDEMIOLOGICAL UPDATE Circulating viruses http://www.thsk.gov.tr/dosya/birimler/bulasici_hastaliklar_db/dokumanlar/grip/2017/haftalik_influenzagrip_surveyans_raporu_2017_ 12_hafta.pdf

TURKEY EPIDEMIOLOGICAL UPDATE Circulating viruses http://www.thsk.gov.tr/dosya/birimler/bulasici_hastaliklar_db/dokumanlar/grip/2017/haftalik_influenzagrip_surveyans_raporu_2017_ 12_hafta.pdf

TURKEY EPIDEMIOLOGICAL UPDATE Subtypes / lineages Of 2833 cases, 758 had influenza positive ( % 26,8) %75 A(H3N2) %25 İnf B %0,1 A (H1N1) %0,2 İnf A Lineages: results pending http://www.thsk.gov.tr/dosya/birimler/bulasici_hastaliklar_db/dokumanlar/grip/2017/haftalik_influenzagrip_surv eyans_raporu_2017_12_hafta.pdf

ACTION PLAN COMPONENTS UPDATE COMPONENTS / Actions Progress achieved since the beginning of MENA ISN? 2017 2018- Future actions to attain (to be completed in September) Challenges SURVEILLANCE Turkey Public Health Institution under MoH, has a website where weekly surveillance data is shared ILI surveillance within the national surveillance system will be strengthened Measuring real efficacy of vaccine Mortality and morbidity data is lacking/not shared VACCINATION Inclusion of pregnant women in the risk groups and prescription based funding of the vaccination through reimbursement list in 2016 Efforts to set the national adult vaccination programme documenting the disease burden through hospitalbased surveillance Lack of a programme to track the immunized/nonimmunized individuals in the target groups VCR is around 2%

ACTION PLAN COMPONENTS UPDATE COMPONENTS / Actions Progress achieved since the beginning of MENA ISN? 2017 2018- Future actions to attain (to be completed in September) Challenges SOCIAL MOBILIZATION / EDUCATION / AWARENESS Turkish Society of Internal Medicine Specialists conducted HCP awareness activities in 11 provinces-elderly project (influenza disease awareness for GPs) Turkish Society of Internal Medicine Specialists will conduct HCP awareness activities 11 new provinces Limited Support of MoH to include FM practitioners into the programme 14 Medical Associations had a press release about influenza disease and importance of vaccination

ACTION PLAN COMPONENTS UPDATE COMPONENTS / Actions Progress achieved since the beginning of MENA ISN? 2017 2018- Future actions to attain (to be completed in September) Challenges SOCIAL MOBILIZATION / EDUCATION / AWARENESS - Include the topic in the health literacy training of trainers programmes conducted by Gazi University in cooperation with MoH for FPs and family health center nurses - Influenza disease education in scientific session of pediatric congress The Health Literacy trainings including scenarios on Influenza and adult vaccination will start to be conducted to HCPs Lack of a national adult immunization programme

ACTION PLAN COMPONENTS UPDATE COMPONENTS / Actions Progress achieved since the beginning of MENA ISN? 2017 2018- Future actions to attain (to be completed in September) Challenges ADVOCACY & POLICY The participation of MoH into updating the Adult Vaccination Guide Circular for pregnant women and risk group vaccination for influenza is sent by MoH to the healthcare staff Communicate the policy makers and HCPs to have an adult vaccination programme Convincing of policy makers to establish an adult vaccination programme including FM pracitioners Attitude of Obst. and Gynecologists

CONCLUSIONS / HIGHLIGHTS Although the risk group and pregnant women vaccination is advocated by the MoH via a circular sent to the field staff, there are areas to be improved: Surveillance data should be used to communicate the risk and develop a more effective vaccination programme, A national adult immunization programme needs to be defined including setting of targets and strategies for the elderly and risk groups Coverage with regard to targeted populations (per risk group) needs to be tracked Evidence based data needs to be communicated with decision makers including the hospital-based surveillance data Effective public awareness campaigns need to be developed and conducted

CONCLUSIONS / HIGHLIGHTS Develop actions to increase vaccination coverage rates in pregnant women, people at risk, elderly and children (vaccination campaigns) Disseminate surveillance and disease burden data through publications. Increase the Evidence-based Communication on Influenza Burden and Benefits of Vaccination

Thank you Prof. Dr. F.Nur BARAN AKSAKAL nuraksakal@gmail.com